Summary: Pharmanovia, in partnership with Lindus Health, announced positive topline results from its open-label RESTORE trial on chloral hydrate for severe insomnia. The trial, which involved 100 adult patients receiving chloral hydrate over 14 days, demonstrated improvements in … [Read more...]
Wearable Sleep Monitors Trigger Alerts for Potential Respiratory Infections. But Do Users Act on Them?
Summary: A Scripps Research study found that only 25% of people act on wearable sensor alerts for respiratory infections by taking at-home tests. The study highlighted the importance of personalized and timely alerts, as those based on symptoms were more effective in prompting … [Read more...]
Exploring the Potential of Psilocin for Sleep Disorders
Summary: Enveric Biosciences announced that its EB-002 psilocin drug candidate has gained expanded protection under US Patent No 11,945,778, covering methods of treating brain neurological disorders, including sleep disorders. This patent joins two others, enhancing the … [Read more...]
A Potential Fix Emerges for Narcolepsy Medication’s Palatability
By Sree Roy Ensuring a drug is absorbed as intended is certainly more important than the medicine’s palatability, but wouldn’t it be great to have both efficacy and a decent taste? For one narcolepsy drug, that conundrum was explored via a poster presentation at SLEEP 2024. … [Read more...]
Suvorexant: A Potential Solution for Opioid Addiction
Summary: Suvorexant, an insomnia drug, prevents opioid addiction in mice when given with morphine, without inducing sleep and while maintaining effective pain relief. The drug blocks hypocretin receptors, which are linked to mood and addiction. The study shows that suvorexant … [Read more...]
Diabetes Drug Shows Potential as Sleep Apnea Treatment
Summary: New evidence published in the New England Journal of Medicine demonstrates that tirzepatide, a drug developed for diabetes, significantly reduces the severity of obstructive sleep apnea (OSA) in patients with obesity. Conducted by researchers at the University of … [Read more...]
NIH Targets Long COVID in Trials Testing Potential Treatments
Two phase 2 clinical trials to test the safety and effectiveness of three treatments for adults with autonomic nervous system dysfunction from long COVID have begun. The autonomic nervous system acts largely unconsciously and regulates bodily functions, such as heart rate, … [Read more...]
Samsung Unpacks the Potential of AI for Better Sleep at SXSW
At the 2024 South by Southwest Festival in Austin, Texas, Samsung led a panel discussion on the current state of sleep quality and the potential of artificial intelligence (AI) and technology in enhancing sleep. Panelists included Hon Pak, MD, senior vice president and head of … [Read more...]